aldosterone has been researched along with Blood Clot in 28 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Aldosterone plays a key role in maintaining the homeostasis of the whole organism." | 5.48 | Aldosterone modulates blood homocysteine and cholesterol in coronary artery disease patients - a possible impact on atherothrombosis? ( Glowacki, R; Karolczak, K; Kubalczyk, P; Pietruszynski, R; Watala, C, 2018) |
| " Longer duration or higher dosage of spironolactone seems to be more effective in improving cardiovascular system status in PD patients." | 5.46 | Aldosterone antagonist therapy and its relationship with inflammation, fibrosis, thrombosis, mineral-bone disorder and cardiovascular complications in peritoneal dialysis (PD) patients. ( Donderski, R; Grajewska, M; Manitius, J; Miśkowiec, I; Odrowąż-Sypniewska, G; Siódmiak, J; Stefańska, A; Stróżecki, P; Sulikowska, B, 2017) |
| " Therefore, the mechanism of aldosterone prothrombotic action is multiple and involves primary haemostasis activation, procoagulative and antifibrinolytic action, NO bioavailability impairment and oxidative stress augmentation." | 2.46 | [Prothrombotic aldosterone action--a new side of the hormone]. ( Chabielska, E; Gromotowicz, A; Mantur, M; Osmólska, U; Szemraj, J; Szoka, P; Zakrzeska, A, 2010) |
| "Atherosclerosis is characterized by the thickening of the arterial wall and is the primary cause of coronary artery disease and cerebrovascular disease, two of the most common causes of illness and death worldwide." | 2.44 | Translating molecular discoveries into new therapies for atherosclerosis. ( Daugherty, A; Rader, DJ, 2008) |
| "Obesity is a common problem in much of the western world today in that is linked directly with several disease processes, notably, hypertension." | 2.42 | Hypertension and obesity. ( Aneja, A; El-Atat, F; McFarlane, SI; Sowers, JR, 2004) |
| "Aldosterone plays a key role in maintaining the homeostasis of the whole organism." | 1.48 | Aldosterone modulates blood homocysteine and cholesterol in coronary artery disease patients - a possible impact on atherothrombosis? ( Glowacki, R; Karolczak, K; Kubalczyk, P; Pietruszynski, R; Watala, C, 2018) |
| " Longer duration or higher dosage of spironolactone seems to be more effective in improving cardiovascular system status in PD patients." | 1.46 | Aldosterone antagonist therapy and its relationship with inflammation, fibrosis, thrombosis, mineral-bone disorder and cardiovascular complications in peritoneal dialysis (PD) patients. ( Donderski, R; Grajewska, M; Manitius, J; Miśkowiec, I; Odrowąż-Sypniewska, G; Siódmiak, J; Stefańska, A; Stróżecki, P; Sulikowska, B, 2017) |
| "Venous thrombosis was induced by stasis in Wistar rats." | 1.37 | Study of the mechanisms of aldosterone prothrombotic effect in rats. ( Chabielska, E; Gromotowicz, A; Jaroszewicz, E; Mantur, M; Rogowski, F; Stankiewicz, A; Szemraj, J; Zakrzeska, A, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (32.14) | 18.7374 |
| 1990's | 1 (3.57) | 18.2507 |
| 2000's | 7 (25.00) | 29.6817 |
| 2010's | 6 (21.43) | 24.3611 |
| 2020's | 5 (17.86) | 2.80 |
| Authors | Studies |
|---|---|
| Gromotowicz-Poplawska, A | 2 |
| Flaumenhaft, R | 1 |
| Gholami, SK | 1 |
| Merrill-Skoloff, G | 1 |
| Chabielska, E | 5 |
| Williams, GH | 1 |
| Romero, JR | 1 |
| Sugioka, S | 1 |
| Yamada, H | 1 |
| Ishii, A | 1 |
| Kato, Y | 1 |
| Yamada, R | 1 |
| Mori, KP | 1 |
| Ohno, S | 1 |
| Handa, T | 1 |
| Ikushima, A | 1 |
| Ishimura, T | 1 |
| Osaki, K | 1 |
| Tokudome, T | 1 |
| Matsusaka, T | 1 |
| Nebreda, AR | 1 |
| Yanagita, M | 1 |
| Yokoi, H | 1 |
| Henry, BM | 1 |
| Vikse, J | 1 |
| Benoit, S | 1 |
| Favaloro, EJ | 1 |
| Lippi, G | 1 |
| Ostermann, M | 1 |
| Lumlertgul, N | 1 |
| Forni, LG | 1 |
| Hoste, E | 1 |
| Szoka, P | 2 |
| Zakrzeska, A | 3 |
| Kolodziejczyk, P | 1 |
| Marcinczyk, N | 1 |
| Szemraj, J | 4 |
| Tutka, P | 1 |
| Donderski, R | 1 |
| Stróżecki, P | 1 |
| Sulikowska, B | 1 |
| Grajewska, M | 1 |
| Miśkowiec, I | 1 |
| Stefańska, A | 1 |
| Siódmiak, J | 1 |
| Odrowąż-Sypniewska, G | 1 |
| Manitius, J | 1 |
| Karolczak, K | 1 |
| Kubalczyk, P | 1 |
| Glowacki, R | 1 |
| Pietruszynski, R | 1 |
| Watala, C | 1 |
| Lagrange, J | 1 |
| Li, Z | 1 |
| Fassot, C | 1 |
| Bourhim, M | 1 |
| Louis, H | 1 |
| Nguyen Dinh Cat, A | 1 |
| Parlakian, A | 1 |
| Wahl, D | 1 |
| Lacolley, P | 1 |
| Jaisser, F | 1 |
| Regnault, V | 1 |
| Elbers, LP | 1 |
| Sjouke, B | 1 |
| Zannad, F | 1 |
| Cicoira, M | 1 |
| Vizzardi, E | 1 |
| Václavík, J | 1 |
| Gerdes, VE | 1 |
| Squizzato, A | 1 |
| Gromotowicz, A | 3 |
| Osmólska, U | 1 |
| Mantur, M | 2 |
| Stankiewicz, A | 2 |
| Jaroszewicz, E | 1 |
| Rogowski, F | 1 |
| Chander, PN | 1 |
| Rocha, R | 1 |
| Ranaudo, J | 1 |
| Singh, G | 1 |
| Zuckerman, A | 1 |
| Stier, CT | 1 |
| O'NEILL, JA | 1 |
| FOSTER, JH | 1 |
| El-Atat, F | 2 |
| Aneja, A | 2 |
| Mcfarlane, S | 1 |
| Sowers, J | 1 |
| McFarlane, SI | 1 |
| Sowers, JR | 1 |
| Bodary, PF | 1 |
| Sambaziotis, C | 1 |
| Wickenheiser, KJ | 1 |
| Rajagopalan, S | 1 |
| Pitt, B | 1 |
| Eitzman, DT | 1 |
| Wojewódzka-Zelezniakowicz, M | 1 |
| Skrzypkowski, P | 1 |
| Rader, DJ | 1 |
| Daugherty, A | 1 |
| Bonchek, LI | 1 |
| Braunwald, NS | 1 |
| Alon, U | 1 |
| Kodroff, MB | 1 |
| Broecker, BH | 1 |
| Kirkpatrick, BV | 1 |
| Chan, JC | 1 |
| Sawyer, A | 1 |
| Isles, CG | 1 |
| Dobbie, JW | 1 |
| Vance, JP | 1 |
| Lever, AF | 1 |
| Stasiński, T | 1 |
| Lehmann, Z | 1 |
| Kostka-Wach, M | 1 |
| Biryńczyk, J | 1 |
| Warenik-Szymankiewicz, A | 1 |
| Gonvers, JJ | 1 |
| Loup, P | 1 |
| Brunner, HR | 1 |
| Mosimann, R | 1 |
| Hofstetter, JR | 1 |
| Hottelart, C | 1 |
| Achard, JM | 1 |
| Moriniere, P | 1 |
| Zoghbi, F | 1 |
| Dieval, J | 1 |
| Fournier, A | 1 |
| Rayner, BL | 1 |
| Robson, SC | 1 |
| Kirsch, RE | 1 |
| Voigt, M | 1 |
| von Knorring, J | 1 |
| Fyhrquist, F | 1 |
| Ahonen, J | 1 |
| Lindfors, O | 1 |
| von Bonsdorff, M | 1 |
| Wood, JE | 1 |
| Crane, MG | 1 |
| Harris, JJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Acute Kidney Injury in COVID-19 Patients Admitted to the ICU: a Multicenter Cohort Analysis in 9 Large Hospitals in Belgium[NCT04997915] | 1,286 participants (Actual) | Observational | 2020-02-01 | Completed | |||
| BNP Pharmacodynamics and Effects on Metabolism in Lean and Obese Subjects[NCT01977859] | Phase 1 | 4 participants (Actual) | Interventional | 2013-11-30 | Completed | ||
| Effect of Nesiritide Infusion on Insulin Sensitivity in Healthy Obese Insulin Resistant Subjects[NCT03234751] | Phase 1 | 6 participants (Actual) | Interventional | 2017-07-13 | Completed | ||
| Comparison of Citrate Dialysate in Predilution and Postdilution Online Hemodiafiltration : Effect on Clot Formation and Adequacy of Dialysis in Hemodialysis Patients[NCT05280106] | 9 participants (Actual) | Interventional | 2022-02-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
9 reviews available for aldosterone and Blood Clot
| Article | Year |
|---|---|
Hyperinflammation and derangement of renin-angiotensin-aldosterone system in COVID-19: A novel hypothesis for clinically suspected hypercoagulopathy and microvascular immunothrombosis.
Topics: Aldosterone; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Immunity, Innate; Inflammati | 2020 |
What every Intensivist should know about COVID-19 associated acute kidney injury.
Topics: Acute Kidney Injury; Aldosterone; Anticoagulants; COVID-19; Critical Care; Critical Illness; Humans; | 2020 |
Effects of mineralocorticoid receptor antagonists on the risk of thrombosis, bleeding and mortality: A systematic review and meta-analysis of randomized controlled trials.
Topics: Aldosterone; Cardiovascular Diseases; Hemorrhage; Hemostasis; Humans; Hyperaldosteronism; Mineraloco | 2016 |
[Prothrombotic aldosterone action--a new side of the hormone].
Topics: Aldosterone; Animals; Eplerenone; Hemostasis; Platelet Adhesiveness; Rats; Spironolactone; Thrombosi | 2010 |
Obesity and hypertension.
Topics: Adipose Tissue; Aldosterone; Body Mass Index; Cardiovascular System; Genetic Predisposition to Disea | 2003 |
Hypertension and obesity.
Topics: Adipose Tissue; Aldosterone; Animals; Body Mass Index; Humans; Hypertension; Inflammation; Insulin R | 2004 |
Hypertension and obesity.
Topics: Adipose Tissue; Aldosterone; Animals; Body Mass Index; Humans; Hypertension; Inflammation; Insulin R | 2004 |
Hypertension and obesity.
Topics: Adipose Tissue; Aldosterone; Animals; Body Mass Index; Humans; Hypertension; Inflammation; Insulin R | 2004 |
Hypertension and obesity.
Topics: Adipose Tissue; Aldosterone; Animals; Body Mass Index; Humans; Hypertension; Inflammation; Insulin R | 2004 |
Translating molecular discoveries into new therapies for atherosclerosis.
Topics: Aldosterone; Animals; Atherosclerosis; Humans; Inflammation; Lipoproteins; Renin-Angiotensin System; | 2008 |
[Effect of oral contraceptives on the circulatory system].
Topics: Aldosterone; Angiotensin II; Cardiovascular Diseases; Cerebrovascular Disorders; Contraceptives, Ora | 1980 |
The cardiovascular effects of oral contraceptives.
Topics: Aldosterone; Angiotensin II; Blood Coagulation; Blood Flow Velocity; Blood Vessels; Cardiovascular S | 1972 |
2 trials available for aldosterone and Blood Clot
| Article | Year |
|---|---|
Enhanced Thrombotic Responses Are Associated With Striatin Deficiency and Aldosterone.
Topics: Aldosterone; Animals; Calmodulin-Binding Proteins; Fibrin; Hypertension; Membrane Proteins; Mice; Ne | 2021 |
Heparin-induced hyperkalemia in chronic hemodialysis patients: comparison of low molecular weight and unfractionated heparin.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Anticoagulants; Bicarbonates; Creatinine; Cross-Over Studi | 1998 |
17 other studies available for aldosterone and Blood Clot
| Article | Year |
|---|---|
Dual deletion of guanylyl cyclase-A and p38 mitogen-activated protein kinase in podocytes with aldosterone administration causes glomerular intra-capillary thrombi.
Topics: Aldosterone; Animals; Endothelial Cells; Guanylate Cyclase; Humans; Mice; Mice, Knockout; Mitogen-Ac | 2023 |
Hyperglycemia Potentiates Prothrombotic Effect of Aldosterone in a Rat Arterial Thrombosis Model.
Topics: Aldosterone; Animals; Diabetes Mellitus, Experimental; Disease Models, Animal; Hyperglycemia; Rats; | 2021 |
Aldosterone antagonist therapy and its relationship with inflammation, fibrosis, thrombosis, mineral-bone disorder and cardiovascular complications in peritoneal dialysis (PD) patients.
Topics: Adult; Aged; Aged, 80 and over; Aldosterone; Biomarkers; Blood Pressure; Cardiovascular Diseases; Ch | 2017 |
Aldosterone modulates blood homocysteine and cholesterol in coronary artery disease patients - a possible impact on atherothrombosis?
Topics: Adrenal Glands; Aged; Aldosterone; Animals; Arachidonic Acid; Cholesterol; Collagen; Coronary Artery | 2018 |
Endothelial mineralocorticoid receptor activation enhances endothelial protein C receptor and decreases vascular thrombosis in mice.
Topics: Aldosterone; Animals; Aorta; Blood Coagulation Factors; Cells, Cultured; Endothelial Cells; Endothel | 2014 |
Study of the mechanisms of aldosterone prothrombotic effect in rats.
Topics: Aldosterone; Animals; Aorta; Biological Availability; Bleeding Time; Hemodynamics; Hemostasis; Male; | 2011 |
Aldosterone plays a pivotal role in the pathogenesis of thrombotic microangiopathy in SHRSP.
Topics: Aldosterone; Animals; Antineoplastic Agents, Hormonal; Blood Pressure; Body Weight; Creatinine; Dexa | 2003 |
THE INFLUENCE OF LOW MOLECULAR WEIGHT DEXTRAN ON LETHAL ENDOTOXEMIA.
Topics: Aldosterone; Dextrans; Dogs; Endotoxemia; Endotoxins; Erythrocyte Aggregation; Escherichia coli Infe | 1964 |
Aldosterone promotes thrombosis formation after arterial injury in mice.
Topics: Aldosterone; Animals; Atherosclerosis; Carotid Artery Injuries; Hyperaldosteronism; Male; Mice; Mice | 2006 |
Acute aldosterone infusion enhances thrombosis development in normotensive rats.
Topics: Aldosterone; Animals; Blood Coagulation; Blood Pressure; Carboxypeptidase B2; Disease Models, Animal | 2007 |
Modification of thrombus formation on prosthetic heart valves by the administration of low molecular weight dextran.
Topics: Aldosterone; Animals; Cattle; Dextrans; Glucose; Heart Valve Prosthesis; Hematocrit; Postoperative C | 1967 |
Renal tubular acidosis type 4 in neonatal unilateral kidney diseases.
Topics: Acidosis, Renal Tubular; Aldosterone; Bicarbonates; Female; Humans; Infant, Newborn; Kidney; Male; N | 1984 |
Acute hypertension after traumatic renal artery thrombosis with high circulating concentrations of angiotensin II.
Topics: Aldosterone; Angiotensin II; Humans; Hypertension, Renal; Hypertension, Renovascular; Male; Middle A | 1982 |
[Treatment of refractory ascites by means of the LeVeen shunt].
Topics: Aldosterone; Ascites; Body Weight; Creatinine; Diuresis; Female; Humans; Male; Middle Aged; Peritone | 1981 |
Renal function, sodium and water homeostasis in patients with idiopathic extrahepatic portal vein thrombosis compared with normal healthy controls.
Topics: Adult; Aldosterone; Case-Control Studies; Creatinine; Female; Glomerular Filtration Rate; Humans; In | 2001 |
Renin/angiotensin system in hypertension after traumatic renal-artery thrombosis.
Topics: Abdominal Injuries; Adult; Aldosterone; Angiotensin II; Blood Pressure; Erythropoietin; Female; Hemo | 1976 |
Desoxycorticosterone secretion rate studies in edematous patients.
Topics: Adult; Aged; Aldosterone; Desoxycorticosterone; Edema; Female; Heart Failure; Humans; Liver Cirrhosi | 1970 |